INTRODUCTION
============

Close to one million people every year are killed by malaria, an infectious disease caused by protozoan parasites of the genus *Plasmodium* (World Malaria Report 2009 <http://www.who.int/malaria/world_malaria_report_2009/en/index.html>), of which *Plasmodium falciparum* is the deadliest. In efforts to understand the parasite's basic biology and discover unique vulnerabilities, several studies have detailed transcriptome-wide RNA expression data during various parasite lifestages ([@B1; @B2; @B3]). However, although more than half of the parasite's genes are predicted to contain introns ([@B4]), no specific transcriptome-wide analysis of splicing in this organism has been performed to date. Splicing, the mechanism by which intronic sequences are removed and exonic sequences are joined together, not only determines the protein coding or functional RNA sequence of a mature transcript but also the regulatory information included in the transcript. Alternative splicing adds an additional layer of complexity by allowing the generation of different mature transcripts from the same precursor, and is crucial to such diverse biology as *Drosophila* sex determination and *HIV-1* replication ([@B5],[@B6]). Thus, a transcriptome-wide picture of splicing and alternative splicing in *P. falciparum* is crucial for recognizing the full regulatory, protein encoding and functional RNA encoding complexities of the transcriptome.

Although the molecular mechanism of RNA splicing remains murky in *P. falciparum*, it has been well studied in model organisms. In the classical pathway, two transesterification steps are catalyzed by the spliceosome, a large complex of small nuclear ribonucleoproteins (snRNPs), each containing an snRNA component and a core set of proteins. snRNAs have been documented in *P. falciparum* ([@B7],[@B8]), but only one protein component, a UAP56 homolog, has been definitively identified ([@B9]). As with splicing components, elucidation of the motifs guiding splicing also remains incomplete. Typically these motifs include the 5′-splice site (AG\|[GU]{.ul}AUGU in yeast, AG\|[GU]{.ul}RAGU in mammals), the branch point sequence (UACUAAC in yeast, YNYURAY in mammals), the poly-pyrimidine tract (variable length in both yeast and mammals) and the 3′-splice site (C[AG]{.ul}\| in yeast, Y[AG]{.ul}\| in mammals) ([@B10]). In *P. falciparum*, EST data have been used to generate putative 5′ (AR\|[GU]{.ul}AANW) and 3′ (Y[AG]{.ul}\|) splice site motifs ([@B7]). As in most eukaryotes, the first and last 2 nt of the intron (5′ GU-AG 3′) are the most consistent markers of intronic sequence. In other organisms, a minority of introns are marked by non-canonical splice sites such as 5′ GC-AG 3′ (recognized by the major U2-type spliceosome) and 5′ AU-AC 3′ (recognized by the minor U12-type spliceosome) ([@B11]). Non-canonical splice sites occur in *P. falciparum* EST data ([@B12],[@B13]) and have been incorporated into some gene models, yet no study to date has documented the types of intron boundaries recognized by the parasite.

Alternative splicing, in which the same precursor transcript can give rise to multiple different mature transcripts, also occurs in the parasite. Although relatively little is known about splicing in general in *P. falciparum*, more than 100 alternative splicing events have been reported in *Plasmodium* species since 1991 ([@B14; @B15; @B16; @B17; @B18; @B19; @B20]). Alternatively spliced isoforms have also been computationally predicted, yet lack experimental validation ([@B21]).

Recent analyses have shown that transcriptome complexity in many organisms extends beyond alternative splicing. Dense transcriptional arrangements, such as overlapping protein-coding genes (in parallel or antiparallel orientation) and natural antisense transcripts ([@B22],[@B23]), now appear to be commonplace rather than anomalous. Although the functional importance of these arrangements is not yet well understood, some are known to be important in regulatory relationships between the paired genes ([@B24]). In current *P. falciparum* gene models, six instances of protein-coding gene overlap are annotated, resulting in one parallel and five antiparallel gene pairs. In addition, RNA polymerase II has been shown to synthesize long antisense transcripts in the parasite ([@B25]), and EST data indicate that at least one of these may be spliced ([@B12]). Short antisense transcripts have also been described ([@B26]).

In this study, RNA-Seq data were generated from four timepoints in the intraerythrocytic transcriptome of *P. falciparum* for the purpose of characterizing splicing in this organism. Unbiased, gene model-independent splice site detection within our data set in conjunction with RNA-Seq data from Otto *et al*. and Sorber *et al*. ([@B14],[@B27]) was accomplished using the HMMSplicer algorithm ([@B28]), which was specifically developed to handle the challenging RNA-Seq data sets generated from the A/T-rich genome of *P. falciparum*. A total of 977 new 5′ GU-AG 3′ and 5 new 5′ GC-AG 3′ junctions never before documented in gene models or ESTs were discovered. Further analysis uncovered alternative splicing events, largely within 254 genes, as well as splicing events antisense to one another. Antisense events, some of which themselves displayed alternative splicing, likely indicate a mix of overlapping annotated genes transcribed from opposite strands and unannotated transcripts transcribed antisense to gene models. Unexpectedly, antisense introns overlap sense gene introns more than would be anticipated by chance, perhaps indicating some relationship between overlapping transcripts, or an inherent feature of transcriptome organization. Over 30 antisense and alternative splicing events were independently experimentally verified, indicating that the new, alternative and antisense splicing events elucidated here support a larger, more dynamic understanding of the parasite's transcriptome.

MATERIALS AND METHODS
=====================

Generation of timepoint samples
-------------------------------

3D7 Oxford *P. falciparum* parasites were grown at 2% hematocrit in 30 × T150 ml flasks with 50 ml of volume each. Repeat synchronization during peak invasion and again 12 h later over three consecutive lifecycles produced 30 ml of packed blood containing 11% highly synchronized late schizont parasites. This starter culture was allowed to invade 140 ml of unparasitized blood in 830 ml of culture medium in a 5 l dished bottom bioreactor (Applikon Inc, Brauwegg, Netherlands). Bioreactor conditions and culture medium were as in Bozdech *et al*. ([@B1]). After 4 h, the culture was diluted to ∼5% hematocrit with 3 l of culture medium. Half (50%) of the culture was harvested 11 h after invasion (TP1), pelleted and frozen at −80°C. Thirty-three percent of the culture was harvested 22 h after invasion (TP2), 10% 33 h after invasion (TP3) and 7% 44 h after invasion (TP4). Total RNA was harvested from frozen pellets using Trizol (Invitrogen Corp., Carlsbad, CA, USA), then poly-A selected using the Micro FastTrack 2.0 kit (Invitrogen Corp.).

Generation of RNA-Seq libraries
-------------------------------

Libraries were generated as in Sorber *et al*. ([@B27]). Briefly, 1.2--1.6 µg of polyA-selected RNA was reverse transcribed using 6bp-EciI-N~9~ (all primers can be found in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)), and second strand cDNA synthesis was carried out with 13-bp-ModSolS-N~9~. Five cycles of PCR were done with 6bp-EciI and biotin-short-Mod-SolS (biotin-short-Mod-PE-SolS for TP1 and TP2 libraries), followed by binding to Dynal Dynabeads M-280 (Invitrogen Corp.). Bead-bound material was digested with EciI, then treated with Antarctic Phosphatase (New England Biolabs, Ipswich, MA, USA). Sol-L-NN annealed adapter was ligated onto cut ends. Five final cycles of PCR were performed on one-fourth of bead-bound material using Sol primer 1 and fullModSolS (fullMod-PE-SolS for TP1 and TP2 libraries). Remaining bead-bound material was subjected to three rounds of Long March using GsuI and the Sol-L-NN annealed adapter ([@B27]). The additional TP4 library sequenced here derived from a fourth Long March of the thrice-marched library described in Sorber *et al*. annealed to the Sol-L-AC-NN adapter ([@B27]). Final PCR on marched sub-libraries was as described for initial libraries.

Illumina sequencing of RNA-Seq libraries
----------------------------------------

For TP1-3, the initial library and the thrice-marched sub-library were clustered on an Illumina flow cell in separate lanes (Illumina, Hayward, CA, USA). For single-end libraries and the first read of paired-end libraries, Sol-SeqPrimer was used as the sequencing primer, and PE-SolS-SeqPrimer was used to sequence the second read of paired-end libraries. Up to 60 single base extensions were performed with image capture using an Illumina GA2 sequencer (Illumina; [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). The Illumina Pipeline software suite version 0.2.2.6 (Illumina) was utilized for base calling from these images for TP3 and TP4, and versions 1.3.2 and 1.5.0 were used to base call TP1 and TP2 images. All primary sequencing data can be found in the NCBI Short Read Archive under accession number SRA024324.1.

Analysis pipeline
-----------------

Raw sequence data from the above timecourse as well as from Otto *et al*. and Sorber *et al*. ([@B14],[@B27]) were aggregated and any barcodes were removed. Reads with greater than 12 nt of adapter sequence, a repeat of A, T, C, G, or AT longer than 11 nt, or more than 10 nt with a quality scores ≤5 were discarded. Identical sequences within a timepoint were compressed to a single sequence read and the reads were filtered to remove human sequences, as detected by BLAST against the human genome with an *E*-value of 1 × 10^−5^ ([@B29]).

To gauge overall coverage, the filtered read set was aligned to the *P. falciparum* genome, PlasmoDB version 6.3 ([@B30]), by Bowtie version 0.12.1, using default parameters except that alignment of reads with multiple matches was disallowed ([@B31]). Reads unaligned by Bowtie were then aligned using BLAT version 34 with a tile size of 11, a step size of 1, and using an ooc file to filter repetitive sequence ([@B32]). Bowtie alignments were combined with BLAT alignments score ≥35 to yield the final set of aligned reads from which coverage statistics were generated.

To detect exon--exon spanning reads, HMMSplicer v0.7.0 was run in parallel on the filtered read set against the *P. falciparum* genome, PlasmoDB version 6.3 with a minimum intron size of 5 nt, a maximum intron size of 1000 nt and an anchor size of 6 nt ([@B28]). All other parameters were left at default values.

Operational definitions for data analysis
-----------------------------------------

To avoid confusion, a specific terminology was used to refer to specific parts of individual splice junctions and to classify junctions ([Supplementary Figure S1A--D](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). For all definitions referencing gene models, a junction maps to a gene model only if at least one inner edge falls within the bounding coordinates of the gene model.

A 'known junction' maps to the same pair of inner boundaries as a splice junction found in PlasmoDBv6.3 gene models or in EST data ([Supplementary Figure S1B](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). A 'new junction' maps to a pair of boundaries not seen in PlasmoDBv6.3 gene models or in EST data. 'Canonical junctions' map to 5′ GU-AG 3′ boundaries, while 'noncanonical junctions' map to all other possible boundaries. A 'junction conflict' occurs when an inner edge of one junction falls within the intronic portion of the other junction such that they must occur in a mutually exclusive manner ([Supplementary Figure S1C](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). 'Junction groups' were built by randomly selecting a nucleating junction, then searching for all relevant conflicting junctions. These junctions were added to the group and the search was iterated until no new junctions were appended. 'Alternate 5′- and 3′-splice sites' refers to splice junctions where both the 5′- and 3′-splice sites conflict ([Supplementary Figure SC](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). A splice junction that conflicts with two or more junctions that themselves do not conflict is considered a 'skipped exon'. Although such instances could instead be interpreted as independent alternate 5′- and 3′-splice sites, skipped exon interpretation is consistent not only with our own independent experimental validations, but also frequently with gene models. In an 'antisense conflict', two junctions conflict with boundaries on opposite strands ([Supplementary Figure S1D](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). However, 'antisense junctions' must have at least one boundary antisense to a gene model. See [Supplementary Materials and Methods](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1) for analysis beyond these categorizations.

Validation of new splicing events
---------------------------------

In determining which new splicing events to assess, only new junctions that conflicted with recovered known junctions were considered, so that each validation had an internal positive control. In addition, the known isoform had to be ≥30 bp longer than the putative new isoform to ensure a selective restriction digest with size distinguishable final PCR products. The top 20 new junctions for which successful validation schemes could be computationally designed were picked starting with the highest scoring new junction for the group above the threshold, and starting with the highest scoring new junction below 1075 for the group below the threshold.

A biologically independent small-scale timecourse similar to the Bioreactor timecourse was performed using highly synchronous 3D7 Oxford parasites. After total RNA extraction as described above, RNA from each timepoint was reverse transcribed. For each validation, cDNA from the lifecycle stage with the highest representation of the new junction was used in the PCR-restriction digest-PCR scheme depicted in [Figure 2](#F2){ref-type="fig"}A, with products column purified between steps. Appropriate primers and enzymes for each validation are listed in [Supplementary Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1). Size appropriate final PCR bands were gel extracted, then TOPO TA cloned (Invitrogen Corp.). Whole cell PCR products from positive colonies were sequenced using the BigDye Terminator v3.1 Cycle Sequencing Kit on an ABI 3130xl Genetic Analyzer (Life Technologies Corp., Carlsbad, CA, USA). Resulting sequences were trimmed for vector and then aligned to the *P. falciparum* genome (v6.3) using BLAT ([@B32]). See [Supplementary Materials and Methods](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1) for additional details.

RESULTS
=======

*Plasmodium falciparum* contains specific orthologs to splicing factors
-----------------------------------------------------------------------

In *P. falciparum*, RNA components of the major U2-type spliceosome have been detected ([@B7],[@B8]), yet protein components have not been systematically identified. Using reciprocal best hits (RBH) analysis ([@B33]) of human and yeast splicing factors, we identified putative homologs to spliceosome and spliceosome-associated protein components ([Table 1](#T1){ref-type="table"}) ([@B34; @B35; @B36]), the majority of which were most similar to their human counterparts. However, homologs of three components of the human spliceosome could not be identified: SFY2, PPIE and PRP2. PRP2, a DEAH/D-box ATPase, is ostensibly the most critical of the three, as it is thought to induce a structural rearrangement that results in dissociation of the SF3a and b complexes from the branchpoint, rendering the branchpoint competent for nucleophilic attack of the 5′-splice site ([@B37]). Interestingly, initial analysis returned PF10_0294 as the closest match in *P. falciparum* for both human PRP2 and PRP22, though the reciprocal BLAST completing RBH analysis returned PRP22 as a slightly better match for PF10_0294 within the human genome ([Table 1](#T1){ref-type="table"}). PRP2 and PRP22 are both DEAH/D-box proteins involved in splicing with a high degree of conservation between their helicase and C-terminal domains. In *Sachharomyces cerevisiae* and other related yeast, PRP2 proteins contain a conserved DC amino acid doublet in their C-terminal domain that distinguishes them from other closely related DEAH/D-box ATPases, such as PRP22 ([@B38]). Although RBH analysis points to PF10_0294 as a PRP22 homolog, alignment of the C-terminal portion of PF10_0294 reveals the presence of the DC doublet signature of PRP2 homologs in yeast ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Without biochemical characterization, it is difficult to determine which role PF10_0294 might play, and it is possible that it encompasses the activity of both DEAH/D-box ATPases. Thus, while our RBH analysis is helpful as a first step in determining players involved in splicing, careful experimental verification of the exact roles of these putative homologs is still required to fully understand how splicing occurs in *P. falciparum*. Table 1.Putative *P. falciparum* splicing and non-sense-mediated decay factor homologs identified by reciprocal best hits analysis with human or *S. cerevisiae* sequencesComplexHuman/Yeast*Pf* HomologComplexHuman/Yeast*Pf* Homolog**snRNP core** (stability and functionofU1, U2, U4 and U5 snRNPs)SNRPB/SMB1PF14_0146**U4/U6** (catalytic activation of spliceosome)PRPF3/PRP3MAL13P1.45SNRPD1/SMD1PF11_0266NHP2L1/SNU13PF11_0250SNRPD2/SMD2PFB0865wPRPF4/PRP4MAL13P1.385[^a^](#TF1){ref-type="table-fn"}SNRPD3/SMD3PFI0475wPRPF31/*PRP31*PFD0450cSNRPE/SME1MAL13P1.253PPIH/-PF08_0121[^b^](#TF2){ref-type="table-fn"}SNRPF/SMX3PF11_0280**tri-snRNP** (activation of spliceosome)SART1/SNU66PFC1060c[^a^](#TF1){ref-type="table-fn"}SNRPG/SMX2MAL8P1.48USP39/SAD1PF13_0096[^a^](#TF1){ref-type="table-fn"}**U6 core** (stability and function of U6 snRNP)LSM2/LSM2PFE1020wSNRNP27/-MAL8P1.71[^a^](#TF1){ref-type="table-fn"}^,^[^b^](#TF2){ref-type="table-fn"}LSM3/LSM3PF08_0049**hPrp19/CDC5** (specification of U5 and U6 interactions with RNA)PRPF19/PRP19PFC0365wLSM4/LSM4PF11_0524CRNKL1/CLF1PFD0180cLSM5/LSM5PF14_0411CDC5L/CEF1PF10_0327[^a^](#TF1){ref-type="table-fn"}LSM6/LSM6PF13_0142[^b^](#TF2){ref-type="table-fn"}ISY1/ISY1PF14_0688LSM7/LSM7PFL0460wBCAS2/SNT309PFF0695w[^a^](#TF1){ref-type="table-fn"}^,^[^b^](#TF2){ref-type="table-fn"}NAA38/LSM8MAL8P1.9[^b^](#TF2){ref-type="table-fn"}XAB2/SYF1PFL1735c[^a^](#TF1){ref-type="table-fn"}**U1** (initial 5′-ss recognition)SNRNP70/SNP1MAL13P1.338PLRG1/PRP46PFC0100c[^a^](#TF1){ref-type="table-fn"}SNRPA/MUD1MAL13P1.35[^b^](#TF2){ref-type="table-fn"}SYF2/SYF2?SNRPC/YHC1PF08_0084SNW1/*PRP45*PFB0875c[^a^](#TF1){ref-type="table-fn"}**U2** (BP detection)SNRPA1/LEA1PF13_0362BUD31/*BUD31*PFE1140cSNRPB2/MSL1PFI1695cPPIE/-?**U2-related** (BP and poly-Y recognition)U2AF1/-PF11_0200[^b^](#TF2){ref-type="table-fn"}CCDC12/-PF14_0490[^a^](#TF1){ref-type="table-fn"}U2AF2/MUD2PF14_0656[^b^](#TF2){ref-type="table-fn"}AQR/-PF13_0273[^a^](#TF1){ref-type="table-fn"}^,^[^b^](#TF2){ref-type="table-fn"}SF1/MSL5PFF1135wCWC15/*CWC15*PF07_0091[^b^](#TF2){ref-type="table-fn"}**SF3a** (stability ofU2-BaP interaction)SF3A1/PRP21PF14_0713[^a^](#TF1){ref-type="table-fn"}PPIL1/-PFE1430c[^b^](#TF2){ref-type="table-fn"}SF3A2/PRP11PFF0970w**Non-snRNP factors** (second step factors) (RNA release)DHX16/PRP2PF10_0294?[^a^](#TF1){ref-type="table-fn"}SF3A3/PRP9PFI1215wBAT1/SUB2PFB0445c**SF3b** (stability of U2-BP interaction)SF3B1/HSH155PFC0375cDDX46/PRP5PFE0430w[^a^](#TF1){ref-type="table-fn"}SF3B2/CUS1PF14_0587SLU7/SLU7PFF0500cSF3B3/RSE1PFL1680wDHX38/PRP16MAL13P1.322SF3B4/HSH49PF14_0194CDC40/CDC40PFL0970wSF3B5/YSF3PF13_0296PRPF18/*PRP18*PFI1115cPHF5A/RDS3PF10_0179aDHX8/PRP22PF10_0294?[^a^](#TF1){ref-type="table-fn"}SF3B14/-PFL1200c[^b^](#TF2){ref-type="table-fn"}**NMD** (detection of nonsense transcripts)UPF1/NAM7PF10_0057**U5** (catalytic activation of spliceosome)DDX23/PRP28PFE0925cUPF2/NMD2PFI1265w[^a^](#TF1){ref-type="table-fn"}CD2BP2/LIN1PF10_0310[^a^](#TF1){ref-type="table-fn"}UPF3A/UPF3?EFTUD2/SNU114PF10_0041[^b^](#TF2){ref-type="table-fn"}UPF3B/-PF13_0158[^b^](#TF2){ref-type="table-fn"}SNRNP200/ BRR2PFD1060w**SR and hnRNP**SRSF1/-PFE0865c[^b^](#TF2){ref-type="table-fn"}TXNL4A/DIB1PFL1520wSRSF12/-PFE0160c[^b^](#TF2){ref-type="table-fn"}PRPF8/PRP8PFD0265wPTBP2/-PFF0320c[^b^](#TF2){ref-type="table-fn"}PRPF6/*PRP6*PF11_0108SFRS4/-PF10_0217[^b^](#TF2){ref-type="table-fn"}SNRNP40/-MAL8P1.43[^b^](#TF2){ref-type="table-fn"}TRA2B/-PF10_0028[^a^](#TF1){ref-type="table-fn"}^,^[^b^](#TF2){ref-type="table-fn"}[^1][^2][^3]

In other eukaryotes, alternative splicing is guided by the presence or absence of proteins that determine which splice sites are available to the spliceosome ([@B39]). To determine if *P. falciparum* has homologs to such proteins, human arginine/serine-rich (SR) and heterogeneous nuclear ribonucleoproteins (hnRNP) proteins with documented roles in alternative splicing were used for best reciprocal hits analysis ([@B40],[@B41]). Four SR proteins and one hnRNP protein returned specific homologs ([Table 1](#T1){ref-type="table"}). These homologs likely represent only a fraction of the proteins that influence splice site selection in *P. falciparum*, as at least 71 additional proteins contain either an RNA recognition motif (RRM) or an RNA binding domain (RBD) according to InterPro ([@B42]), and 7 contain an RS domain according to our own analysis. Many proteins involved in splice site selection during alternative splicing utilize one or more of these domains, although they do not guarantee involvement in splicing ([@B40],[@B41]). Together these data suggest that alternative splicing could play an important role in *P. falciparum*.

Overview of *P. falciparum* RNA-Seq data sets
---------------------------------------------

To investigate splicing in *P. falciparum* on a transcriptome-wide scale, we generated short read RNA-Seq data from multiple timepoints of a highly synchronous, large-scale, intraerythrocytic culture and analyzed these data, in conjunction with publically available data sets, for splice junctions. To guarantee adequate representation of distinct blood stages, timepoints were collected from the 3D7 Oxford culture approximately 11 (ring), 22 (trophozoite), 33 (late trophozoite/early schizont) and 44 (late schizont) h post-invasion. After total RNA isolation, poly-A RNA was purified and prepared for Illumina sequencing using the Long March protocol ([@B27]). All primary sequencing data can be found in the NCBI Short Read Archive under accession number SRA024324.1. To maximize our transcriptome-wide examination of splicing, we also included two previously published *P. falciparum* RNA-Seq data sets in our analysis: one from seven timepoints within the blood stage of 3D7 parasites by Otto *et al*. ([@B14]) and one from the late schizont timepoint of our experiment ([@B27]).

We aggregated these data and after preliminary filtering and sequence collapsing, ran two analyses in parallel: a Bowtie/BLAT ([@B31],[@B32]) pipeline to align ungapped reads back to the *P. falciparum* genome (PlasmoDBv6.3) and HMMSplicer v0.7.0 ([@B28]) to detect and score exon--exon splice junctions. The Bowtie/BLAT pipeline was able to align between 84 and194 million bases of sequence to the *P. falciparum* genome for each independent timepoint ([Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)) for a total of over 1.5 billion aligned bases. Discounting antigenic variation gene families (272 *var*s, *rifin*s and *stevor*s), each exonic nucleotide of a gene was covered by a median of 59 reads. HMMSplicer was also run on the data set with a minimum intron size of 5 bp and a maximum intron size of 1000 bp, covering 99.6% of all annotated *P. falciparum* introns. More than 1.9 million reads in the combined data set were mapped to junctions ([Supplementary Table S4](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)).

To gauge the quality of the junctions predicted from the combined data set, we examined the distribution of HMMSplicer scores calculated for all predicted 5′ GU-AG 3′ junctions ([Figure 1](#F1){ref-type="fig"}A). HMMSplicer scores reflect both the strength of the junction alignment and the cumulative support for that junction within the data set ([@B28]). The distribution of HMMSplicer scores for canonical *P. falciparum* junctions is clearly bimodal, perhaps indicating predictions of differing reliability. In this organism, PlasmoDB gene models and ESTs provide a set of previously known splice junctions that are likely to be valid ([@B12],[@B30],[@B43],[@B44]) and the distribution of HMMSplicer scores for only those junctions with boundaries matching previously known junctions was found to primarily fall within the higher scoring population. Therefore, an HMMSplicer score of 1075, representing the natural breakpoint in the bimodal distribution, was chosen as an operational threshold for subsequent analysis ([Figure 1](#F1){ref-type="fig"}A). Below this threshold, support for detected junctions decreases rapidly, and thus the false positive rate among these lower-confidence junctions is likely to be higher. However, 13% of all known junctions detected within the combined data set fall below our threshold, indicating the presence of valid junctions with non-ideal coverage, though only 0.1% score below 600 ([Figure 1](#F1){ref-type="fig"}A). While we have enacted an operational threshold, all HMMSplicer junctions regardless of score are accessible for additional analyses ([Supplementary Files S1 and S2](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1), upload at <http://plasmodb.org/cgi-bin/gbrowse/plasmodb/>). Figure 1.(**A**) Histogram of 5′ GU-AG 3′ junctions found by HMMSplicer binned by score. Defaults retain all junctions supported by multiple reads scoring above 400 and all junctions supported by single reads scoring above 600. The grey line plots all reported 5′ GU-AG 3′ junctions, while the red line charts junctions that match previously known junctions in PlasmoDB v6.3 gene models or in ESTs. The blue line charts new junctions. The dashed line drawn at 1075 represents the operational score threshold. (**B**) Breakdown of canonical junctions with scores above 1075, with additional classification of new junctions. 'Outside of gene model' refers to new junctions with at least one inner edge mapped to an intergenic region. 'Within gene model' indicates that both inner edges mapped to the same gene model. 'Neighboring gene models' indicates that the inner edges mapped to neighboring gene models. (**C**) Comparison of the 5′- and 3′-splice site WebLogos for previously known junctions recovered versus new junctions above 1075. WebLogos calculated for human junctions are included for reference. Red bars indicate the 5′ GU-AG 3′ boundaries used for inclusion in each set. The height of each letter indicates the preference strength for that nucleotide at each position.

HMMSplicer analysis of RNA-Seq data reveals new canonical splice junctions
--------------------------------------------------------------------------

HMMSplicer found 7655 5′ GU-AG 3′ junctions above the operational threshold within the combined RNA-Seq data. More than 88% were supported by reads from both time courses. Of these high scoring junctions, 6678 (87.2%) confirm introns in PlasmoDB gene models or ESTs ([Supplementary File S3](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1), upload at <http://plasmodb.org/cgi-bin/gbrowse/plasmodb/>). 977 (12.8%) support new introns, an increase of 11% over the current genome annotation ([Figure 1](#F1){ref-type="fig"}B, [Supplementary File S4](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1), upload at <http://plasmodb.org/cgi-bin/gbrowse/plasmodb/>). 431 (43.9%) of these new junctions fall either totally or partially outside of annotated gene models, suggesting splicing in unannotated untranslated regions (UTRs) or in unannotated genes, whereas 544 (55.4%) align within gene models. As discussed below, many of the new junctions discovered within gene models represent alternative transcript isoforms or splicing of antisense transcripts. Unexpectedly, 2 (0.2%) new junctions map to neighboring genes encoded on opposite strands, suggesting unannotated overlap between these gene pairs.

We sought to lend support to the new 5′ GU-AG 3′ junctions detected by HMMSplicer by calculating WebLogos ([@B45]) from their 5′- and 3′-splice sites. If these new junctions represent true splicing events, they would be predicted to recapitulate the nucleotide preferences found within 5′- and 3′-splice sites of known 5′ GU-AG 3′ junctions. Indeed, no significant differences were observed between our calculated sequence logos for PlasmoDB/ EST matching junctions versus new junctions, and both sets of logos closely matched previously published results ([Figure 1](#F1){ref-type="fig"}C) ([@B7]). In contrast, logos produced from the bottom 10% of new junctions below the operational threshold contained little information other than their 5′ GU-AG 3′ boundaries ([Supplementary Figure S3A](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Efforts to determine a branchpoint motif from the introns defined by our high-scoring canonical junctions yielded no convincing results, similar to Chakrabarti *et al*.'s efforts to determine a branch point motif from a smaller set of EST introns ([@B7]).

The validity of new 5′ GU-AG 3′ junctions was also independently assessed by experimental validation using an biological replicate of our original blood stage timecourse and the strategy described in [Figure 2](#F2){ref-type="fig"}A. Twelve 5′-alternate splice sites, 2 3′-alternate splice sites, 17 skipped exons and 10 spliced antisense transcripts were tested ([Table 2](#T2){ref-type="table"}, [Supplementary Figure S1C and D](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). A total of 19/21 (90.5%) new splicing events ranging in score from 1189.3 to 1544.2 were experimentally confirmed, including a skipped exon in MAL13P1.159 (thioredoxin) and splicing of an antisense transcript mapping to PFF0290w (long chain polyunsaturated fatty acid elongation enzyme) ([Figure 2](#F2){ref-type="fig"}B and C); 13/20 (65%) events below the operational threshold with scores ranging from 984.6 to 1050.5 were also confirmed. Since more than half of these lower scoring events were successfully verified, these validations also confirm that our threshold is conservative---in addition to excluding false positive junctions, it also excludes some true splicing events, such as the 3′-alternate splice site in PFB0279w (conserved *Plasmodium* protein, [Figure 2](#F2){ref-type="fig"}D). Overall, these results indicate that a high percentage of new junctions both above and below the threshold are genuine, although independent confirmation may be required for lower scoring junctions. Figure 2.Validation of new splicing events. (**A**) Shade indicates the relative abundance of each isoform. Initial outer PCR (green arrows) amplifies both isoforms from cDNA. A restriction enzyme then cuts the known isoform. Nested inner PCR (blue arrows) amplifies only the uncut, new isoform, which is then sequence confirmed. Gbrowse ([@B66]) windows depict validation of a skipped exon in MAL13P1.159 (**B**), an antisense junction in PFF0290w (**C**), and an alternate 3′-splice site in PFB0279w (**D**). All HMMSplicer junctions scoring higher than 980 are shown as either dark blue bars (known junctions) or light blue bars (new conflicting junctions). The number of reads supporting each junction is shown in the bars, while the direction of the arrow reflects the direction of the splice sites. Validation sequencing results are shown in magenta. Bowtie coverage for each nucleotide in the window is shown as a histogram. Underneath, the dark blue bars depict PlasmoDB v6.3 gene models with numbers denoting the exons, while the gold bars at the bottom of each window depict ESTs. Table 2.Verification of new junctions in conflict with known junctionsGene namePlasmoDBv6.3 descriptionScoreValidatedTypeFrame-shift?Isoform difference in bp (aa)RTLT/ESSPFL1810wConserved *Plasmodium* protein1544.2Yes5′ssYes1311181151283.2Yes5′ssYes2183031PFE0390wConserved *Plasmodium* protein1422.1Yes5′ssYes65131083PF13_0138MSF-1 like protein1372Yes5′ssYes557537PFI0400cConserved *Plasmodium* membrane protein1369.8YesExon skipNo126 ([@B42])21191PFF0290wLong chain polyunsaturated fatty acid elongation enzyme1291.8YesAntisense--N/A96145MAL13P1.225Thioredoxin1277.3YesExon skipYes342600PFE0055cHeat shock protein1275.4Yes5′ssNo36 (12)541438MAL8P1.126Serine protease1257.4Yes5′ssYes10911118PF10_0025PF70 protein1256.8Yes5′ssYes7418200PFD1050wAlpha-tubulin II1243.2--Antisense--N/A1051MAL13P1.159[^a^](#TF3){ref-type="table-fn"}Thioredoxin1239.9YesExon skipNo33 ([@B11])0103PFC0780wCleavage and polyadenylation specific factor1231.7--Antisense--N/A26278PFD0775cRNA binding protein1228.4YesAntisense--N/A1680PF10_0194NoOP12-like protein1219.4YesExon skipYes411001PFL1440cConserved *Plasmodium* protein1217.6YesExon skipNo57 ([@B19])0201PF11_0291Conserved *Plasmodium* protein1203.5Yes5′ssNo39 (13)1005PFC0360wActivator of HSP90 ATPase homolog 1-like protein1200.5YesExon skipYes2231130PFC0495wPlasmepsin VI1192.6YesAntisense--N/A0083PF14_0394Conserved *Plasmodium* protein1190Yes5′ssYes982450MAL13P1.146AMP deaminase1189.3Yesantisense--N/A1100PF11_0379Conserved *Plasmodium* protein1050.5YesExon skipNo60 ([@B20])1001PFL1445wConserved *Plasmodium* protein1041.3YesExon skipYes850600MAL13P1.16SNARE protein1034.7YesExon skipNo108 ([@B36])0004MAL13P1.277DNAJ-like protein1034.2YesExon skipYes1462030PFF1210wPhosphatidic acid phosphatase1032.4Yes5′ssNo66 (22)2035PFB0600cConserved *Plasmodium* protein1026.1YesAntisense--N/A1130PF14_0128Ubiquitin conjugating enzyme1018.5YesExon skipYes1040130PF14_0316DNA topoisomerase II1011.4--5′ssNo459 (153)0031PFB0279w[^a^](#TF3){ref-type="table-fn"}Conserved *Plasmodium* protein1010.9Yes3′ssYes971430PFL1465cHeat shock protein hslv1004.5--Exon skipYes400204PF10_0372Antigen UB051004.4--antisense--N/A0101PF11_0182Conserved *Plasmodium* protein1004.1YesExon skipYes560050PFF0365cG-protein associated signal transduction protein996.3--Exon skipYes1632000PFB0445cDEAD box helicase, UAP56995.9--3′ssYes741000PFD0895cBet3 transport protein991--Antisense--N/A0020PF10_0116Conserved *Plasmodium* protein989.9Yes5′ssYes740020PF14_0604Conserved *Plasmodium* protein988.1YesExon skipYes3441000PFI0560cConserved *Plasmodium* protein987.7YesExon skipYes401002PFB0550wPeptide chain release factor subunit 1985.5--Exon skipYes1550020PF11_0355Conserved *Plasmodium* protein984.6YesAntisense--N/A1100[^4][^5]

Our results suggest both that a number of true positive junctions exist below our operational threshold and that the nucleotide preferences present at the 5′- and 3′-splice sites of known junctions do not hold for the lowest scoring, least reliable junctions in the data set. Therefore, to attempt recovery of true 5′ GU-AG 3′ junctions below our operational threshold, an orthogonal score based on position specific scoring matrices ([@B46]) of the splice site logos was evaluated. Although this type of motif scoring ultimately lacked sufficient information for large-scale computational rescue ([Supplementary Figure S3B](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)), it could potentially be used to prioritize experimental assessment of new junctions ([Supplementary File S5](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)).

Inspection of non-canonical splice junctions reveals new 5′ GC-AG 3*′* junctions
--------------------------------------------------------------------------------

In many eukaryotes, splicing occasionally occurs at non-5′ GU-AG 3′ boundaries, sometimes via the major U2-type spliceosome as with 5′ GC-AG 3′ introns ([@B47]), or via the minor U12-type spliceosome as with 5′ AT-AC 3′ introns ([@B48]), or spliceosome-independently as with the 5′ CA-AG 3′ intron in yeast HAC1 ([@B49]). The presence of 5′ GC-AG 3′ junctions in *P. falciparum* ESTs and gene models ([@B12],[@B13]) suggests that the parasite uses 5′ GC non-canonical splice sites, yet this likelihood has never been examined in detail. Of the 984 non-canonical junctions above our operational threshold ([Supplementary File S6](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1), upload at <http://plasmodb.org/cgi-bin/gbrowse/plasmodb/>), 12 map to 5′ GC-AG 3′ boundaries ([Supplementary Table S5](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Of these, 7 were supported by either EST evidence or annotated PlasmoDB gene models, and 5 were completely new. We used WebLogo v3.0 to construct 5′- and 3′-splice site sequence logos from all 12 5′ GC-AG 3′ junctions ([@B45]) ([Figure 3](#F3){ref-type="fig"}). The 3′-splice site logo was very similar to the canonical 3′-splice site logo. However, several clear differences distinguished the 5′-splice site logo for 5′ GC-AG 3′ junctions from that of canonical junctions. Whereas canonical *P. falciparum* 5′-splice sites have a slight preference for AG as the last two bases of the 5′-exon, all 12 5′ GC-AG 3′ examples contain AG in these positions, and all 12 also contain an A at the third position of the intron. These same 3 nt are also present in the two PlasmoDB 5′ GC-AG 3′ junctions with HMMSplicer scores below our operational threshold. Both the fourth and fifth positions of 5′ GC-AG 3′ introns also appear to have strong, although not absolute, nucleotide preferences. Though stronger contextual sequence may simply reflect the small number of input sequences, stronger consensus 5′-splice site motifs have been documented for 5′ GC-AG 3′ introns in other organisms as well ([@B11]). As with 5′ GU-AG 3′ introns, efforts to determine a branchpoint motif from these introns failed to produce any convincing results. Figure 3.WebLogo 5′- and 3′-splice site motifs for high scoring 5′ GC-AG 3′ HMMSplicer junctions (*n* = 12). Red bars indicate the boundaries used for inclusion in the set. The height of each letter indicates the information content for that nucleotide at each position. The large error bars derive from the small size of the input set.

We also considered the possibility that the parasite might employ splice sites other than 5′ GU-AG 3′ and 5′ GC-AG 3′. However, preliminary manual inspection of the remaining non-canonical junctions revealed that many of them were likely to be false positives caused by read errors. Polymerase slipping, template switching, and single base pair substitutions are well-documented phenomena ([@B50; @B51; @B52]) that can occur during both the reverse transcription and PCR steps of library preparation. These upstream errors have no associated cost in sequence quality, and therefore may explain the origins of high scoring, erroneous junction reads. Since the probability of an erroneous read mapping to non-canonical boundaries is much greater than the probability of it mapping to canonical boundaries, it is not surprising that the false positive rate within the non-canonical junctions is higher than within the canonical junctions.

Two additional filters designed to eliminate false positive junctions while retaining any potential true non-canonical junctions were applied to the non-canonical junctions ([Supplementary Materials and Methods](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Since HMMSplicer is more sensitive to errors the closer they are to the true breakpoint of a junction read ([@B28]), the first filter eliminated non-canonical junctions with single base substitutions within 15 bp of either inner edge that caused miscalling of the junction breakpoint (343 of 972 junctions). The second filter removed non-canonical junctions in very highly covered regions since the probability of error creation during preparation and sequencing increases as the copy number for a given sequence increases (356 of 629 remaining junctions). As an internal check, neither filter eliminated any of the 12 5′ GC-AG 3′ junctions previously identified.

Manual inspection of the remaining 273 non-canonical junctions yielded no additional, credible non-canonical splice junctions. Although 5′ AT-AC 3′ splice sites have been observed in introns excised by the U12 minor spliceosome ([@B48]), failure to detect any in the RNA-Seq data is consistent with our failure to find *P. falciparum* homologs to proteins specific to the human U12-type spliceosome ([@B53]). Similarly, a previous search by Lopez *et al*. for all snRNAs in a variety of eukaryotes returned no minor spliceosome snRNAs in any *Apicomplexa*, including the two rodent *Plasmodium* species examined ([@B54]). Together, these results indicate that *P. falciparum* is unlikely to possess a minor U12-type spliceosome.

Genome-wide characterization of alternative splicing
----------------------------------------------------

Alternative splicing increases transcriptome complexity by generating multiple isoforms from the same precursor that differ in single 5′- or 3′-splice sites or in whole exons and introns. To find alternative splicing within the combined data set in an unbiased manner, independent of gene models, high scoring canonical and 5′ GC-AG 3′ junctions were compared to each other in a pair wise manner. To be considered 'conflicting junctions', one of the inner edges of a junction must have aligned within the intronic area of the other junction ([Supplementary Figure S1B](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Since direct counting of these occurrences would over-inflate the number of alternative splicing events (for example, a single skipped exon event would count as two pair-wise conflicts), conflicts were further aggregated into junction groups ([Supplementary Figure S1B](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)), which were then divided by strand orientation where applicable ([Supplementary File S7](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). In total, 196 (48.3%) alternate 5′-splice sites, 145 (35.7%) alternate 3′-splice sites, 8 (2.0%) mutually exclusive alternate 5′- and 3′-splice sites and 56 (13.8%) skipped exons were tallied ([Figure 4](#F4){ref-type="fig"}A). The majority of alternative splicing events occurred in gene models in the sense direction, though some also occurred outside of gene models. These intergenic events most likely indicate alternative splicing in unannotated *P. falciparum* UTRs or in unannotated genes. Interestingly, all four types of alternative splicing were also seen in antisense junction groups. Further analysis of antisense splicing events is discussed in the next section. Figure 4.Breakdown of alternative splicing events detected transcriptome-wide. (**A**) Alternative splicing events both by type and area in the genome. Events 'In gene models' belong to junction groups in which at least one junction maps within a gene model in the sense direction. 'Intergenic' events belong to junction groups with no junctions mapping to gene models. 'Antisense' events occur in junction groups with at least one junction within a gene model in the antisense direction. (**B**) Breakdown of the 279 alternative splicing events that have the potential to change the gene model's coding sequence. 'Frameshift-unclear' could not be analyzed for ORF extension or truncation without assuming which downstream junction(s) co-occur in a given isoform. (**C**) Histogram of alternative splicing (AS) junctions (*n* = 296) by ratio of AS junction reads to recovered gene model (GM) junction reads. In cases of conflict with more than one GM junction, the GM junction with the most reads was chosen as the denominator.

Because the combined RNA-Seq data are comprised of short reads rather than full length mRNAs, the collection of splice junctions that compose a given isoform is difficult to resolve, and thus the exact number of isoforms encoded by the alternative splicing events described here could not be determined. However, transcriptome-wide, the combined data set supports the existence of between 279 and 369 alternative isoforms (533 and 623 total isoforms) for the 254 genes in which conflicting junctions were detected ([Supplementary File S7](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Alternative splicing events for most genes maximally support between 2 and 4 isoforms. However, a handful of genes \[PF14_0338 (conserved *Plasmodium* protein), PFF0630c (conserved *Plasmodium* protein), PFL1440c (conserved *Plasmodium* protein), PFC0495w (plasmepsin VI), and PFC0912w (signal peptidase)\] could encode up to 8--16 different isoforms. In addition to supporting up to 8 sense isoforms, an overlapping antisense junction was also validated for PFC0495w (plasmepsin VI), making it particularly interesting ([Table 2](#T2){ref-type="table"}). Gene ontology (GO) analysis of alternatively spliced genes did not reveal any functional patterns ([Supplementary Materials and Methods](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)).

The transcriptome complexity afforded by alternative splicing often increases the number of distinct proteins encoded by an organism. Of the 310 *P. falciparum* alternative splicing events mapped to gene models in the sense direction, 10% are predicted to produce altered UTRs, while the remaining 279 (90%) are predicted to produce distinct coding sequences. Of these, close to one third maintain coding frame, either adding or removing amino acids from the predicted protein ([Figure 4](#F4){ref-type="fig"}B). In contrast, the majority of alternative splicing events result in frameshifts, most of which introduce premature termination codons within the gene model's predicted coding sequence.

One explanation for the abundance of protein truncating alternative splicing events in *P. falcparum* is that these transcripts may not be translated, but instead could be intermediates bound for non-sense-mediated decay (NMD). Regulated splicing controlling the ratio of NMD-targeted to protein-coding isoform produced from certain genes is a mechanism of post-transcriptional regulation in other organisms ([@B39],[@B55]). However, NMD has not been shown to exist in the parasite. Using human and yeast sequences for the core conserved NMD surveillance proteins, UPF1, UPF2 and UPF3 (paralogs UPF3a and UPF3b in humans) ([@B56]), best reciprocal hits analysis was able to find homologs to all three in *P. falciparum*, suggesting the NMD pathway exists in this parasite ([Table 1](#T1){ref-type="table"}). While it is unclear what the trigger for NMD may be in *P. falciparum*, 119 (73%) of the 162 truncating events do so \>50 bp upstream of the last splice junction, rendering them eligible for NMD in mammalian systems ([@B56]). Regardless, our results suggest that the majority of alternative splicing events in the blood stages of *P. falciparum* either produce truncated protein isoforms or tune gene expression post-transcriptionally.

We also looked at the relative abundance of alternate junctions in comparison to their recovered gene model counterparts ([Figure 4](#F4){ref-type="fig"}C). Many occurred at \<10% of the frequency of the conflicting gene model junction within the combined data sets, and may correspond to isoforms either targeted for non-sense-mediated decay or of minimal use in the blood stages. Interestingly, 33 alternative junctions occurred at ≥100% of the frequency of their conflicting gene model counterparts, indicating that the gene model isoform of the transcript may not be the dominant blood stage isoform ([Supplementary Table S6](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)).

A minority of introns are poorly spliced in *P. falciparum*
-----------------------------------------------------------

Previous reports of alternative splicing in *P. falciparum* have noted instances of transcripts with retained introns ([@B12]), and regulated splicing efficiency can control such important biology as onset of meiosis in *S. cerevisiae* ([@B57]). Therefore, to gauge general splicing efficiency as well as to discover poorly spliced outlier introns, we calculated the ratio of junction reads to the average number of reads covering both cognate exon--intron borders ([@B58]). Only recovered gene model junctions in genes without mapped antisense junctions were considered to avoid complicating factors. Because the data sets analyzed here were not generated specifically for the purpose of analyzing splicing efficiency, calculations could be made for only a subset of splice junctions in which the read counts covering both exon--intron borders were relatively similar ([Supplementary Materials and Methods](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). For the 779 introns analyzed, junction reads were recovered a median of five times more often than exon--intron reads ([Supplementary File S8](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). However, 44 (5.6%) analyzed introns appear to be very poorly spliced in the blood stages as they are retained in at least 50% of the transcripts sampled here.

A subset of new junctions within genes challenge their corresponding gene models
--------------------------------------------------------------------------------

Although gene models were not consulted during detection of junctions or alternative splicing, we assessed how thoroughly they were encompassed by our results. Of the 8435 predicted splice junctions in PlasmoDB v6.3 gene models, 1103 were not observed in the combined data set, even below our operational threshold. Gene models with unrecovered splice junctions had a median coverage of six reads per coding nucleotide, indicating that in general, these genes were not substantially expressed during the blood stages. However, for 50 unrecovered known junctions, new junctions above the operational threshold were observed that did not match the boundaries indicated by the gene model ([Supplementary Table S7](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Although it is possible that the gene model isoforms are not expressed in the blood stages in these cases and that the new junctions represent blood stage-specific alternate isoforms, it is more likely that the corresponding gene models are incorrect.

Genome-wide characterization of antisense splicing
--------------------------------------------------

While probing for conflicting junctions, we noticed a class of conflicts in which one junction contained intron boundaries on a given strand while the other mapped to intron boundaries on the opposite strand ([Supplementary Figure S1D](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Although none of the data sets analyzed here were derived from a directional library, the orientation of intron boundaries has been used in the past to assign direction to ESTs ([@B59]). In addition, antisense transcription has been previously noted in *P. falciparum* ([@B60]), and ESTs antisense to gene models have also been documented ([@B12]). Therefore, it is likely that these 'antisense conflicts' derive from overlap of two spliced transcripts transcribed in opposite directions.

To expand on the initial discovery of antisense conflicts, we searched for all high scoring junctions with at least one intron boundary antisense to an annotated gene model. This analysis differed from the conflicting junctions analysis in two important ways. First, it incorporated antisense junctions that do not conflict with any sense introns ([Supplementary Figure S1D](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Second, it excluded antisense conflicts between junctions in which neither mapped to a gene model (four independent conflicts), and thus neither could be deemed 'sense' or 'antisense'. In total, this list contains 200 antisense junctions mapping to 149 gene models ([Supplementary File S9](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). In addition, antisense junctions overlapping 16 of these genes appear to undergo alternative splicing to produce between 38 and 59 different isoforms (example shown in [Figure 5](#F5){ref-type="fig"}A, [Supplementary File S7](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Weblogos of the 5′- and 3′-splice sites of antisense junctions revealed no significant differences compared to known junctions ([Figure 5](#F5){ref-type="fig"}B), suggesting that antisense junctions arise from the same mechanism as other splice junctions in the transcriptome. No GO terms were significantly enriched within genes with mapped antisense junctions ([Supplementary Materials and Methods](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Figure 5.Characterization of antisense splice junctions. (**A**) Schematic of all sense and antisense junctions recovered for PFD1050w (α-tubulin II). (**B**) WebLogos of the 5′- and 3′-splice sites of antisense junctions. The height of each letter indicates the preference strength for that nucleotide at each position. (**C**) Observed and expected distributions of antisense intron overlap with sense introns. The expected distribution was calculated by first determining the probability of encountering a GU (5′-splice site) or an AG (3′-splice site) on the opposite strand of introns versus exons in the genes with mapped antisense junctions. These probabilities guided otherwise random re-placement of each antisense junction within its corresponding gene model. This re-placement was iterated 100 times, with the mean percent of nucleotide overlap with sense introns ± standard deviation shown.

Antisense junctions could derive from either overlap between neighboring gene models encoded on opposite strands of the genome or from unannotated transcripts antisense to gene models. Indeed, 23 antisense junctions could be attributed to overlap between 15 pairs of neighboring annotated genes on opposite strands based on linking junctions or ESTs ([Supplementary Table S8](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). Only one gene pair (PFE1425c/PFE1420w) is annotated as overlapping, while nine had prior EST evidence of overlap. The remaining five pairs had no prior evidence of overlap. Twelve pairs were arranged in a tail-to-tail (overlapping 3′-ends) fashion, while three were arranged in a head-to-head (overlapping 5′-ends) fashion. Several studies have reported a bias toward tail-to-tail overlaps in mammalian genomes ([@B61]), although others refute this assertion ([@B23]).

Overlap between annotated genes, however, could not explain all antisense junctions observed in the RNA-Seq data. Of the 177 antisense junctions without direct evidence of neighboring gene overlap, 49 map to genes where neighbors on either side are on the same strand. This observation argues strongly for the presence of unannotated transcripts overlapping annotated genes in an antisense manner. We further investigated whether these 177 antisense junctions might belong to coding or non-coding transcripts. Genomic sequence 300 nt upstream and downstream of each junction was merged and translated in all three frames, and the length of the longest open reading frame (ORF) that crossed the junction was assessed. Of 177 junctions, only 16 occurred in an ORF greater than 300 bases long (average exon size in intron-containing genes is 552 bases). It is possible that these antisense junctions connect shorter than average exons, or occur in UTR regions of unannotated genes. It is also possible that many of them belong to non-coding transcripts. Further elucidation of the structure of these antisense transcripts is necessary to determine their primary function.

Interestingly, over 86% of antisense junctions map to intron-containing genes, though only slightly more than half of genes in *P. falciparum* contain introns. This bias is significant, with a binomial probability of ∼3e^−24^. A similar bias was seen in *Arabidopsis thaliana* in tail-to-tail overlapping transcripts ([@B22]), and could be explained by preferential overlap between introns in antisense transcripts and introns in sense transcripts ([Supplementary Figure S1D](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1)). In some cases, multiple antisense introns overlap extensively with multiple sense gene introns in the same gene model, but not with more expansive exon regions ([Figure 5](#F5){ref-type="fig"}A). The observed distribution of overlap with sense introns is highly statistically significant (*P*-value of chi-squared test \<0.001) when compared to the expected distribution from random re-placement of antisense junctions within their associated genes ([Figure 5](#F5){ref-type="fig"}C). This expected distribution was calculated by first determining the probability of encountering a GU (5′-splice site) or an AG (3′-splice site) on the opposite strand of introns versus exons within the group of genes with mapped antisense junctions. These probabilities then guided otherwise random re-placement of each antisense junction within its corresponding gene model, keeping the original length of the antisense intron intact. After re-placement, the distribution of overlaps for simulated antisense introns with sense introns was tallied. This re-placement was iterated 100 times, with the mean percent of nucleotide overlap with sense introns ± standard deviation shown. Thus antisense introns appear to not only overlap intron-containing sense genes significantly more often than expected, but also overlap the intron portions of sense genes significantly more than expected.

DISCUSSION
==========

Completion and preliminary annotation of the *P. falciparum* genome in 2002 facilitated a series of large-scale experiments designed to illuminate the parasite's biology on a genomic-, transcriptomic- or proteomic-wide level. In pursuit of a thorough understanding of *P. falciparum* blood stage genetic regulation, steady-state gene expression experiments captured its unique, cascade-like transcriptome ([@B1],[@B2]). Subsequent genome-wide RNA decay experiments revealed global rapid turn over of RNA in the early hours post-invasion, and then progressively longer transcript half-lives during the remainder of the blood stage cycle ([@B62]). The new splicing events described here reveal additional complexities within the transcriptome not captured by these previous studies, such as alternative splicing, gene overlap and spliced antisense transcripts, and thus, the present study fits into a larger, more dynamic understanding of the transcriptome of *P. falciparum*.

Traditionally, full-length cDNA and EST data have been used for analysis of transcript structure and variants. EST collections in *P. falciparum* have indeed produced increasingly accurate gene models ([@B12],[@B13],[@B43],[@B44]). However, no full-length cDNA sequences have been published for *P. falciparum*, and many gene models lack or are incompletely covered by ESTs. RNA-Seq provides the advantage of capturing an entire transcriptome at great depth, enabling detection of low copy number transcripts and variants. However, in its current form, RNA-Seq cannot capture a single transcript molecule from beginning to end. Despite this limitation, the orders-of-magnitude increase in throughput over EST libraries expanded the repertoire of splice junctions known in the parasite by \>11% in the present study.

The ability to accurately and sensitively map junction reads from the RNA-Seq data sets proved crucial to our analysis. For this purpose, we used HMMSplicer, an algorithm we developed specifically to overcome the challenges presented by RNA-Seq data and the inherent biases within the *P. falciparum* genome ([@B28]). In contrast to previous RNA-Seq studies in *P. falciparum* and other organisms ([@B14],[@B63]), we relied only on alignment of junction reads within the genome to detect splice junctions, rather than depending on gene models or ungapped read coverage. Also, HMMSplicer does not use additional assumptions to filter its output junction set, instead scoring each splice junction on the strength of supporting reads. Because a low false positive rate was desired for accurate characterization of splicing in *P. falciparum*, we established an operational HMMSplicer score threshold based on the bimodal distribution of known versus new canonical splice junctions. However, setting this threshold held the disadvantage of excluding some known junctions, and therefore some true new junctions as well. Indeed, our biologically independent validation experiments demonstrated that even lower scoring junctions were more likely than not to represent true splicing events. Although these lower scoring junctions were excluded from downstream analysis in the present study, they remain accessible in the HMMSplicer results ([Supplementary Files S1 and S2](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1), upload at <http://plasmodb.org/cgi-bin/gbrowse/plasmodb/>).

We also did not rely on gene models during discovery of alternative splicing. This decision was prompted by several observations within the data. First, there were ambiguous instances in which a junction conflicted with a gene model, but the gene model junction was not recovered within the data set. These instances could potentially represent gene model errors, making it inappropriate to classify them as alternative splicing without additional data. Conversely, areas of the transcriptome with no gene model contained multiple junctions that could not possibly exist within the same transcript ([Figure 4](#F4){ref-type="fig"}A). These intergenic junction groups clearly exhibit alternative splicing and would have been missed by reliance on gene models. Thus our unbiased approach allowed for more accurate and sensitive detection of alternative splicing events based solely on experimental observation of the conflicting junctions themselves.

Although *P. falciparum* ESTs and even some gene models include non-canonical 5′ GC-AG 3′ splice junctions, to our knowledge, no study has attempted to identify or characterize non-canonical junctions in *P. falciparum*. We found 12 high scoring 5′ GC-AG 3′ junctions within the non-canonical junctions results, 5 of which were new. As in other organisms, the 5′-splice site for these junctions has a remarkably high information content compared to the 5′-splice site for canonical *P. falciparum* junctions, perhaps indicating greater reliance on sequence context for recognition of 5′ GC splice sites. In particular, the strong preference for G at the fifth position in 5′ GC-AG 3′ introns is interesting. Although G is strongly preferred at this position in human canonical introns ([@B11]), and mutation of this G to other bases reduces splicing fidelity in yeast ([@B64]), *P. falciparum* canonical introns have almost no base preference at this position ([Figure 1](#F1){ref-type="fig"}C) ([@B7]). At present, it is unclear how complete the list of 5′ GC-AG 3′ junctions is, given that the percent of splice junctions mapping to those splice sites (∼0.1%) remains several fold lower in *P. falciparum* than in other organisms ([@B11]). In addition, although filters designed to aid discovery of any additional non-canonical junctions were implemented, manual inspection found no convincing examples. It is possible that despite efforts to limit bias, the filters inadvertently eliminated true positive junctions or manual inspection failed to detect credible non- 5′ GU-AG 3′ or 5′ GC-AG 3′ junctions within the data.

Our analysis uncovered not only constitutive and alternative splicing in *P. falciparum*, but also complex transcriptional arrangements in the parasite. Independent validation of new junctions antisense to sense junctions indicates that these are not artifacts of the RNA-Seq technique. Rather, antisense junctions in the data suggest overlap between annotated sense genes and antisense transcripts, some of which appear to be extensions of neighboring annotated genes, while others are likely unannotated. For unknown reasons, antisense splice junctions tend to encompass sense introns more than would be expected by chance. It is unknown if this phenomenon is specific to *P. falciparum* antisense splice junctions, as it has not been explored in other organisms to our knowledge. Perhaps antisense introns must be spliced out in approximately the same area as sense introns to allow transcript pairs to physically interact with one another. Conversely, if the low complexity sequence that comprises *P. falciparum* introns generally does not encode useful information on either strand, it would have to be removed from both sense and antisense transcripts to preserve function. Further inquiry is necessary to distinguish between these hypotheses.

The larger impact of the transcriptome features revealed by the new canonical and 5′ GC-AG 3′ junctions captured here remains unknown. Consistent with reports correlating alternative splicing prevalence with organismal complexity ([@B65]), alternative splicing events do not appear to be widespread in *P. falciparum* blood stages, affecting 8.6% of intron-containing genes. Although relatively scarce, alternative splicing events in *P. falciparum* may expand important protein functionalities in the organism and may also contribute to crucial post-transcriptional gene regulation---however, it is possible that their impact on parasite biology is minimal. Interestingly, these events appear to occur with almost no pressure to preserve ORFs, as only one-third are predicted to do so, the same proportion expected by chance. We have suggested that alternative splicing events predicted to result in truncated ORFs may be linked to a NMD system in the parasite as a means of gene regulation. It would be interesting to determine if such isoforms decay faster than their corresponding protein-coding isoforms, perhaps by extending previous methods for determining RNA decay rates in *P. falciparum* using high-throughput sequencing. Unfortunately, current RNA decay data in *P. falciparum* does not allow for discrimination between the decay rates of isoforms of the same transcript ([@B62]). The observed overlap between sense and antisense transcript pairs of may also contribute to important gene regulation in the parasite by a variety of mechanisms ([@B24]). In addition, unannotated antisense transcripts could perform a variety of as-yet-unknown functions that may or may not be restricted to regulation of their sense partners. Unraveling these possibilities in both the symptomatic blood stages of *P. falciparum* as well as in the organism's larger lifecycle will provide an unprecedented understanding of a deadly human pathogen.

ACCESSION NUMBER
================

SRA024324.1.

SUPPLEMENTARY DATA
==================

[Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkq1223/DC1) are available at NAR Online.

FUNDING
=======

Howard Hughes Medical Institute; National Science Foundation (DGE-0648991). Funding for open access charge: Howard Hughes Medical Institute.

*Conflict of interest statement*. None declared.

Supplementary Material
======================

###### Supplementary Data

The authors would like to thank Dr Quinn Mitrovich for technical expertise in devising the junction validation strategy. We would also like to thank Alex Plocik for helpful discussions during article preparation, Dr Polly Fordyce for insightful reorganization of the article and Dr Steven Brenner for analysis advice and suggestions.

[^1]: The human or *S. cerevisiae* factor in bold font represents the best match for the *P. falciparum* homolog. Homologs of spliceosomal and NMD factors not found are denoted with question marks, while SR and hnRNP factors not found are not shown. *Saccharomyces cerevisiae* homologs that do not reside in the same complex as their human counterparts are italicized.

[^2]: ^a^*Plasmodium falciparum* proteins described in PlasmoDB as 'conserved *Plasmodium* protein' or with descriptions that do not reflect involvement in splicing.

[^3]: ^b^Homologs identified only by the human sequence.

[^4]: Conflicts are ranked by lowest HMMSplicer score within the pair, and the black line denotes the operating HMMSplicer threshold of 1075.

[^5]: ^a^Validations shown in more detail in [Figure 2](#F2){ref-type="fig"}. For all conflict types except antisense, the new junction was evaluated for maintenance of the ORF---nucleotide and amino acid (if applicable) differences between new and known isoforms are listed. Read counts for new junctions (normalized by the number of reads mapped by Bowtie for each timepoint) are listed for ring \[R, (TP1, TP0, TP8)\], troph \[T, (TP2, TP16, TP24)\], late troph/early schizont \[LT/ES, (TP3, TP32)\] and schizont \[S, (TP4, TP40, TP48)\] timepoints.
